MDSAP as a Multi-Country Medical Device QMS Reduction Strategy
How a Medical Device Single Audit Program audit can reduce quality-system audit duplication across participating and accepting markets.
How to use it
Use one regulatory QMS audit to support Canada, the United States, Brazil, Japan, Australia, and other markets that recognize or rely on MDSAP evidence.
Treat MDSAP as a QMS strategy, not as a product approval certificate.
Positive impact
- Can be a prerequisite, substitute, or strong audit-reliance tool depending on the target country.
- Useful when planning multi-market filings that include Canada, Australia, Brazil, Japan, and the United States.
Limits and caveats
- MDSAP does not replace product registration, technical evidence, clinical evidence, labeling, or local holder requirements.
- Non-participating markets may treat it only as an ISO 13485/QMS credibility signal.
Country impact matrix
Impact levels are conservative planning signals. Confirm the current accepted-reference list, product scope, and risk class before filing.